2024 HFSA Heart Failure Seminar: Focus on Cognitive Impairment
Cognitive impairment is prevalent in patients living with heart failure and was recently shown to negatively impact functional abilities, life expectancy, medication management and patient self-care. Clinicians have a responsibility to recognize and address cognitive impairment as an integral component of personalized care for patients with heart failure (HF).
The HFSA Heart Failure Seminar: Focus on Cognitive Impairment in Heart Failure features co-authors Eiran Gorodeski, MD, MPH, FHFSA, and Parag Goyal, MD, MSc, FHFSA, as they identify key takeaways from the Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement. They are also joined by co-authors Larry Allen, MD, MHS, FHFSA, Robert DiDomenico, PharmD, FHFSA, and Connie White-Williams, PhD, RN, for an open discussion and Q&A session.
Target Audience
This activity is intended for cardiologists, interventional cardiologists, primary care physicians, cardiac surgeons, internists, nurse practitioners, physician assistants, nurses, pharmacists, and other health care providers who care for patients with heart failure.
Learning Objectives
At the conclusion of this activity, learners will be better able to:
- Explain the impact of cognitive impairmeent on patients with heart failure.
- Discuss the importance of addressing cognitive impairment in heart failure care.
- Apply key recommendations from the Heart Failure Society of America Scientific Statement on Cognitive Impairment.
- Facilitate interdisciplinary collaboration in addressing cognitive impairment in heart failure.
Content Outline
Top Takeaways from the Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement
E. Gorodeski P. Goyal
Panel Discussion with the Co-Authors of the Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement
E. Gorodeski P. Goyal L. Allen R. DiDomenico C. White-Williams
Accreditation Statement
In support of improving patient care, The Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Heart Failure Society of America designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity includes participation in the evaluation component.
This educational activity is approved for nursing continuing professional development (NCPD) units by the Heart Failure Society of America. This activity is approved for a maximum of 1.0 contact hours.
The Heart Failure Society of America is an accredited provider of continuing pharmacy education (CPE). This educational activity is accredited for up to 1.0 contact hours of knowledge-based CPE. ACPE Universal Activity Numbers (UAN): JA4008267-0000-24-007-L01-P (live attendance only); JA4008267-0000-24-008-H01-P (on-demand/home study)
Learners should claim only the credit commensurate with the extent of their participation in the activity.
Related Resource(s)
Goyal P. Didomenico RJ, Pressler SJ, et al. Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement . j Card Fail. 2024;30(3):488-50.
doi:10.1016/j.cardfail.2024.01.003
Important Date(s)
Originally recorded May 21, 2024.